You have Thanksgiving turkey to thank for LASIK
In November 1981, a group of IBM researchers found that it was possible to use lasers to safely cut into living tissue. Thanks to some leftover turkey, we now have corrective surgeries like LASIK.
In November 1981, a group of IBM researchers found that it was possible to use lasers to safely cut into living tissue. Thanks to some leftover turkey, we now have corrective surgeries like LASIK.
The Thanksgiving dinner table isn’t the most common place to be inspired to invent. All the turkey and sides might make most people think about dozing off rather than coming up with ways to change the lives of millions of people around the world. But 40 years ago this week, a group of IBM researchers relied on a turkey just like the one you’ve probably just dug into to help uncover the process that would evolve into LASIK laser eye surgery.
In September 1969, after earning his PhD in applied physics at Harvard, James Wynne joined IBM Research at the company’s lab in Zurich. He returned to the U.S., joining the Thomas J. Watson Research Center in January 1971. At the Watson lab in New York, he was given a simple mandate by his manager, John Armstrong (who later became director and vice president of IBM Research), in the laser science department: “Do something great.” Wynne probably didn’t think that would involve overseeing shooting experimental lasers at turkey bones, but that is exactly where it led.
By the mid-1970s, researchers had been able to demonstrate the feasibility of excimer lasers, a new invention at the time and that could emit far-ultraviolet (UV) light. “The smartest thing I ever did for IBM was when the excimer laser became commercially available, I bought one for my group,” Wynne said. He convinced Armstrong to purchase the laser, as he believed there to be new capabilities the group could unlock through studying what the far-UV light from that laser could do.
A member of the laser physics and chemistry group that Wynne managed, Rangaswamy Srinivasan, had been experimenting with far-UV light to study how it could be used to etch polymers for things like circuit boards. “In 1980, he found that the excimer laser could photoetch and make beautiful clean holes in the plastic without any additional chemical development,” Wynne said. “Wherever the laser beam struck, it would etch away the material and leave a beautiful clean hole.”
Although Srinivasan had been concerning himself with using the laser primarily for etching plastics, he realized that the chemical bond in plastic that was absorbing the laser’s light was also in tissue. “It’s the peptide bond,” Wynne said. In 1981, the team began to wonder if they could use excimer lasers to cut human tissue and potentially aid in precision surgeries. “We talked about what tissue samples we might test it on; we used it on our fingernails and our hair — but we were afraid to shine it on our skin,” Wynne said.
Looking under an electron microscope at the hair samples, they could see that the holes the laser created were free from any burn marks, or what Wynne called “collateral damage.” A picture of one of Srinivasan’s etched hairs has since been on several covers of books on laser refractive surgery, Wynne said.
Forty years ago this week, a group of IBM researchers relied on leftover Thanksgiving turkey to help uncover the process that would evolve into LASIK laser eye surgery.
Even with the promising results, the group was still hesitant to shine the laser on anyone’s skin. But thankfully, on this Thanksgiving, not everyone had cleaned their plates at Srinivasan’s dinner table. He brought in leftovers to the lab the day after Thanksgiving and decided to irradiate a piece of cartilage still attached to a turkey bone. The laser again made a clean, burn-free incision, and over the next week or so, Srinivasan and his colleague Sam Blum tested out the laser on other pieces of turkey cartilage.
After collecting their results, they showed Wynne what they had found. He attempted to recreate the findings with a different type of laser, a Q-switched, frequency doubled The neodymium:yttrium-aluminium-garnet-(Nd:YAG) laser is capable of producing a near-infrared wavelength, used for material etching and some medical procedures.neodymium (Nd) YAG laser that emitted green light, and failed, with that laser burning and charring the sample of cartilage. “That for me was the moment of discovery — we had a new form of laser surgery from our cooked turkey cartilage,” Wynne said.
Over the next few weeks, the three scientists sat down to write an invention disclosure, which is the first step in applying for a patent on a novel invention. They tried to think of every possible use case for what they’d uncovered, and wrote the invention disclosure in such a way as to cover all human and animal tissue.
Over the intervening year, the group decided to test the laser on themselves, and Wynne put himself first on the line. He was still an avid Wynne actually lost to an extremely talented youngster named Arthur Ashe at the Eastern Clay Courts Championship in Hackensack, N.J., in the summer of 1962, before realizing a career in physics was more likely than winning a major tennis tournament.tennis player at the time, and being a righty, he stuck his right hand in his pocket and exposed his left pinky to the laser. The sensation, he said, was similar to blowing a puff of air on his finger. “There was no heat, no pain itself,” Wynne said, with the group realizing they might have a new form of painless surgery on their hands. But they still hadn’t been thinking about eye surgery specifically when their patent application was filed in 1982.
Srinivasan, Wynne, and Blum wrote up their findings in a paper, which was published in Laser Focus. Srinivasan was invited to speak at the CLEO Conference on lasers in May, 1983, where two ophthalmologists from Columbia University were in attendance, heard Srinivasan’s presentation and read the team’s paper. They hypothesized that the excimer laser could be used to reshape an eye’s cornea without creating any collateral damage. One of them visited the Watson Research Center in July, bringing along an enucleated calf eye to test the laser on, and found that it could make precise, clean incisions in the cornea.
Over the next few years, the technology was further refined, and the first corrective laser eye surgery on a sighted person took place in March, 1988. The FDA first approved a system for PRK eye surgery, a less invasive form of corrective eye surgery, in 1995, and approved a system for LASIK eye surgery in 1997.
Since 1990, some 60 million people across the world have had their eyesight corrected by laser surgery, including Wynne’s own son. When Wynne, Srinivasan, and Blum (who had recently passed away) were awarded the National Medal of Technology and Innovation by President Obama in 2013, they learned that even First Lady Michelle Obama had undergone laser refractive surgery.
IBM sold the patent that Wynne’s team had worked on in 1997, but he has continued to research the potential of excimer lasers in surgery. He focuses now on what he calls a “smart scalpel,” publishing a paper on his research1 in 2018. The aim is to be able to remove dead and damaged tissue from burn victims, especially children, without any damage to the underlying and adjacent viable tissue.
The next time you’re being scolded at the Thanksgiving dinner table to stop playing with your food, you should remind everyone that it might just lead to the next major scientific breakthrough. Or maybe just some charred turkey.
Notes
- Note 1: The neodymium:yttrium-aluminium-garnet-(Nd:YAG) laser is capable of producing a near-infrared wavelength, used for material etching and some medical procedures. ↩︎
- Note 2: Wynne actually lost to an extremely talented youngster named Arthur Ashe at the Eastern Clay Courts Championship in Hackensack, N.J., in the summer of 1962, before realizing a career in physics was more likely than winning a major tennis tournament. ↩︎
References
-
Prasad, A., Sawicka, K., Pablo, K., et al. ArF excimer laser debrides burns without destruction of viable tissue: A pilot study. ScienceDirect. Volume 44, Issue 3, 2018, Pages 589-595, ISSN 0305-4179. ↩